Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Azotemic osteodystrophy - indications for intervention

Progress in Biochemical Pharmacology

|January 1, 1980

Summary

This summary is machine-generated.

Understanding azotemic osteodystrophy remains challenging. While treatments can normalize some blood markers in advanced kidney disease, they are less effective for bone health, necessitating further research into effective interventions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

De novo glomerulonephritis in patients during remission from Wegener's granulomatosis.

Clinical nephrology·1992

Same author

Reduced capillary density in the myocardium of uremic rats--a stereological study.

Kidney international·1992

Same author

Renal histology in polycystic kidney disease with incipient and advanced renal failure.

Kidney international·1992

Same author

The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease.

Journal of the American Society of Nephrology : JASN·1992

Same author

Severe hemorrhagic complications from infection with nephropathia epidemica strain of Hantavirus.

Clinical nephrology·1992

Same author

Disturbed calcium metabolism in renal failure--pathogenesis and therapeutic strategies.

Kidney international. Supplement·1992

Same journal

Dietary fiber research.

Progress in biochemical pharmacology·1990

Same journal

Biologically active ether lipids.

Progress in biochemical pharmacology·1988

Same journal

Effect of changes in intracellular pH on the contractility of rat resistance vessels.

Progress in biochemical pharmacology·1988

Same journal

Vasoreactive effects of hypothalamic sodium transport inhibitor.

Progress in biochemical pharmacology·1988

Same journal

Platelet-activating factor and the cardiovascular system: involvement in cardiac anaphylaxis.

Progress in biochemical pharmacology·1988

Same journal

Synthesis of biologically active ether lipids.

Progress in biochemical pharmacology·1988

See all related articles

Area of Science:

Nephrology
Endocrinology
Bone Metabolism

Background:

Pathogenesis of azotemic osteodystrophy is not fully understood.
Prophylactic and therapeutic interventions are suboptimal.
Secondary hyperparathyroidism is a key concern in renal failure.

Purpose of the Study:

To review current understanding and management of azotemic osteodystrophy.
To evaluate the efficacy of various treatments in renal failure.
To identify gaps in knowledge regarding bone disease in chronic kidney disease.

Main Methods:

Review of existing literature on azotemic osteodystrophy.
Analysis of treatment outcomes for phosphate binders, vitamin D, and hemodialysis.
Discussion of challenges in managing bone histology.

Related Experiment Videos

Main Results:

Phosphate binders and vitamin D normalize serum chemistry but not bone histology in advanced renal failure.
Hemodialysis normalizes mineral levels but does not prevent hyperparathyroidism or metabolic bone disease.
Osteitis fibrosa responds to vitamin D, but osteomalacia shows limited response.

Conclusions:

Current treatments for azotemic osteodystrophy offer limited improvement in bone histology.
Further research is needed to understand and treat osteomalacia effectively.
Parathyroidectomy is reserved for severe, refractory hyperparathyroidism.